The Economist
@TheEconomist
News and analysis with a global perspective, since 1843. We’re here to help you understand the world around you. Subscribe here:
加入 May 2007
150 正在关注 26.3M 粉丝
America’s drug regulator has already approved an orexin agonist for narcolepsy, a disorder that leaves patients excessively sleepy by day and prone to nod off without warning. But hopes for this new drug type do not end there
显示更多
